Regression of cellular hypertrophy after left ventricular assist device support

Circulation

Volumn 98, Issue 7, 1998, Pages 656-662

  Zafeiridis, Andreas ^a   Jeevanandam, Valluvan ^a   Houser, Steven R ^a   Margulies, Kenneth B ^a  

^a TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Cardiomyopathy; Heart assist device; Hypertrophy; Myocytes

Indexed keywords

ARTICLE; ASSISTED CIRCULATION; CELL STRUCTURE; CELL VOLUME; CONTROLLED STUDY; ECHOCARDIOGRAPHY; GEOMETRY; HEART MUSCLE CELL; HEART VENTRICLE REMODELING; HUMAN; HUMAN CELL; HUMAN TISSUE; PRIORITY JOURNAL; STRESS;

EID: 0032544226     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.98.7.656     Document Type: Article

References (30)

1. Roberts WC, Ferrans VJ. Pathologic anatomy of the cardiomyopathies. Hum Pathol. 1975;6:287-342.
2. Beltrami CA, Finato N, Rocco M, Feruglio GA, Puricelli C, Cigola E, Quaini F, Sonnenblick EH, Olivetti G, Anversa P. Structural basis of end-stage failure in ischemic cardiomyopathy in humans. Circulation. 1994;89:151-163.
3. Gerdes AM, Kellerman SE, Malec KB, Schocken DD. Transverse shape characteristics of cardiac myocytes from rats and humans. Cardioscience. 1994;5:31-36.
4. Gerdes AM, Moore JA, Kelleman SE, Clark LC, Schocken DD. Similar change in cardiac myocyte shape in patients with ischemic and dilated cardiomyopathy. Circulation. 1992;86(suppl I):I-425. Abstract.
5. Thompson EW, Thomas AM, Cornelius EU, Kent RL, Cooper G. Atrophy reversal and cardiocyte redifferentiation in reloaded cat myocardium. Circ Res. 1984;54:367-377.
6. Thomas AM, Brody E, Lauva IK, Kent RL, Cooper G. Reversibility of the structural effects of pressure overload hypertrophy of cat right ventricular myocardium. Anat Rec. 1986;214:141-147.
7. Campbell SE, Korecky B, Rakusan K. Remodeling of myocyte dimensions in hypertrophic and atrophic rat hearts. Circ Res. 1991;68: 984-996.
8. Cooper G, Thomas AM. Complete reversibility of cat right ventricular chronic progressive pressure overload. Circ Res. 1984;54:323-331.
9. Cooper G, Tomanek RJ. Load regulation of the structure, composition, and function of mammalian myocardium. Circ Res. 1982;50:788-798.
10. Savage RM, McCarthy PM, Stewart WJ. Intraoperative transesophageal echocardiographic evaluation of the implantable left ventricular assist device. Video J Echocardiogr. 1992;2:125-136.
11. Levin HR, Chen JM, Oz MC, Catanese KA, Krum H, Goldsmith RL, Packer M, Rose EA. Potential for left ventricular assist devices as outpatient therapy while awaiting transplantation. Ann Thorac Surg. 1994; 58:1515-1520.
12. Frazier OH, Benedict CR, Radovancevic B, Bick RJ, Capek P, Springer W, Macris MP, Delgado R, Buja LM. Improved left ventricular function after chronic left ventricular unloading. Ann Thorac Surg. 1996;62: 675-681.
13. Levin HR, Oz MC, Chen JM, Packer M, Rose EA, Burkhoff D. Reversal of chronic ventricular dilation in patients with end-stage cardiomyopathy by prolonged mechanical unloading. Circulation. 1995;91:2717-2720.
14. Nakatani S, McCarthy PM, Kottke-Marchant K, Harasaki H, James K, Savage RM, Thomas JD. Left ventricular echocardiographic and histologic changes: impact of chronic unloading by an implantable ventricular assist device. J Am Coll Cardiol. 1996;27:894-901.
15. Schenin SA, Caper P, Radovancevic B, Duncan JM, McAllister HA, Frazier OH. The effect of prolonged left ventricular support on myocardial histopathology in patients with end-stage cardiomyopathy. ASAIO J. 1992;38:M271-M274.
16. Altemose G, Gritsus V, Jeevanandam V, Goldman B, Margulies KB. Altered myocardial phenotype after mechanical support in human beings with advanced cardiomyopathy. J Heart Lung Transplant. 1997;16: 765-773.
17. Frazier OH, Rose EA, Macmanus Q, Burton N, Leftak E, Poirier V, Dasse K. Multicenter clinical evaluation of the Heartmate 1000 IP left ventricular assist device. Ann Thorac Surg. 1992;53:1180-1190.
18. Sahn DJ, DeMaria A, Kisslo J, Weyman AE. Recommendations regarding quantitation in M-mode echocardiography: results of a survey of echocardiographic measurements. Circulation. 1978;58:1072-1083.
19. Devereux RB, Alonso DR, Lutas EM, Gottlieb GJ, Campo E, Sachs EI, Reichek N. Echocardiographic assessment of left ventricular hypertrophy: comparison with necropsy findings. Am J Cardiol. 1986;57:450-458.
20. Oh JK, Seward JB, Tajik AJ. The Echo Manual. Boston. Mass: Little, Brown and Co; 1994:43-49.
21. Gerdes AM, Moore JA, Hines JM, Kirkland PA, Bishop SP. Regional differences in myocyte size in normal rat heart. Anal Rec. 1986;215: 420-426.
22. Hurley J. Sizing particles with Coulter counter. Biophys J. 1970;10: 74-79.
23. Nash GB, Tatham PER, Powell T, Twist TV, Speller RD, Loverock LT. Size measurements on isolated rat heart cells using Coulter analysis and light scatter flow cytometry. Biochim Biophys Acta. 1979; 587:99-111.
24. Fraticelli A, Josephson R, Danziger R, Lakatta E, Spurgeon H. Morphological and contractile characteristics of rat cardiac myocytes from maturation to senescence. Am J Physiol. 1989;257:H259-H265.
25. Anversa P, Beghi C, Kikkawa Y, Olivetti G. Myocardial infarction in rats: infarct size, myocyte hypertrophy, and capillary growth. Circ Res. 1986;58:26-37.
26. Olivetti G, Capasso JM, Meggs LG, Sonnenblick EM, Anversa P. Cellular basis of chronic ventricular remodeling after myocardial infarction in rats. Circ Res. 1991;68:856-869.
27. Gerdes AM, Kellerman SE, Moore JA, Muffy KE, Clark LC, Reaves PY, Malec KB, McKeown PP, Schocken DD. Structural remodeling of cardiac myocytes in patients with ischemic cardiomyopathy. Circulation. 1992;86:426-430.
28. Kajstura J, Zhang X, Liu Y, Szoke E, Chang W, Olivetti G, Hintze TH, Anversa P. The cellular basis of pacing-induced dilated cardiomyopathy. Circulation. 1995;92:2306-2317.
29. Scholz D, Diener W, Schaper J. Altered nucleus/cytoplasm relationship and degenerative structural changes in human dilated cardiomyopathy. Cardioscience. 1994;5:127-138.
30. James KB, McCarthy PM, Thomas JD, Vargo R, Hobbs RE, Sapp S, Bravo E. Effect of implantable left ventricular assist device on neuroendocrine activation in heart failure. Circulation. 1995;92(suppl II):II-191-II-195.